CV Sciences (CVSI) Net Margin (2013 - 2026)

CV Sciences (CVSI) reported Net Margin of 20.13% for Q1 2026, down 1710.0% on a YoY basis from 1.25% in Q1 2025, and down 513.38% sequentially from 4.87% in Q4 2025.

CV Sciences (CVSI) Net Margin (2013 - 2026) Analysis & Trends

CV Sciences (CVSI) has 14 years of Net Margin data on file, last reported at 20.13% in Q1 2026.

  • For the quarter ending Q1 2026, Net Margin fell 1710.0% year-over-year to 20.13%; the trailing twelve-month figure through Mar 2026 stood at 8.41% (up 213.0% YoY), and the FY2025 full-year result was 4.29%, up 1096.0% from the prior year.
  • Net Margin declined to 20.13% in Q1 2026, from 4.87% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 137.56% in Q1 2023 to a low of 86.35% in Q2 2022.
  • A 5-year average of 14.2% and a median of 14.77% in 2024 frame the typical range for Net Margin.
  • Across the five-year window, Net Margin jumped 18512 bps in 2023 and tumbled 15325 bps in 2024, its largest moves.
  • Tracing CVSI's Net Margin over 5 years: stood at 59.78% in 2022, then jumped by 62 bps to 22.86% in 2023, then surged by 48 bps to 11.97% in 2024, then jumped by 141 bps to 4.87% in 2025, then slumped by 513 bps to 20.13% in 2026.
  • Business Quant data shows CVSI's Net Margin at 20.13% in Q1 2026, 4.87% in Q4 2025, and 11.73% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 9.29%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 26.57%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -33.66%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 35.18%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 5.03%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 24.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 4.16%
10 CV Sciences 3.74 Mn 3.43 Mn 1.56 Mn -20.13%

Historic Data

Download Data
DateValue
Mar 31, 2026 -20.13%
Dec 31, 2025 4.87%
Sep 30, 2025 -11.73%
Jun 30, 2025 -7.21%
Mar 31, 2025 -3.02%
Dec 31, 2024 -11.97%
Sep 30, 2024 -11.80%
Jun 30, 2024 -14.77%
Mar 31, 2024 -15.69%
Dec 31, 2023 -22.86%
Sep 30, 2023 -10.93%
Jun 30, 2023 -32.48%
Mar 31, 2023 137.56%
Dec 31, 2022 -59.78%
Sep 30, 2022 -27.49%
Jun 30, 2022 -86.35%
Mar 31, 2022 -47.56%
Dec 31, 2021 -178.25%
Sep 30, 2021 -0.78%
Jun 30, 2021 -68.84%